CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Submits Statement in Response to House Ways and Means Health Subcommittee Hearing
Federal Funding Gaps Leave Children Waiting for Specialty Care
Pediatrics Isn’t Adult Care — And Workforce Policy Should Reflect That
CHA Submits Statement in Response to House Ways and Means Health Subcommittee Hearing
Ensuring that children can access timely, specialized care requires continued federal commitment for a strong and sustainable pediatric workforce.
March 11, 2026
Federal Funding Gaps Leave Children Waiting for Specialty Care
Report links Medicaid underpayment and structural funding problems for training to access gaps – and outlines targeted federal reforms.
March 10, 2026
Pediatrics Isn’t Adult Care — And Workforce Policy Should Reflect That
Children rely on a highly specialized workforce, yet policies continue to be built around adult care models. To protect access for kids, CHA offers pediatric‑specific solutions.
March 10, 2026
